Krishnan Viswanadhan
Director/Board Member presso CARGO THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Krishnan Viswanadhan is currently the Director at JW Therapeutics (Shanghai) Co., Ltd.
He is also an Independent Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd., an Independent Director at Cargo Therapeutics, Inc., and the President & Chief Operating Officer at Be Biopharma, Inc. Previously, he worked as the Vice President-Business Development at Celgene Corp.
and as a Program Manager at F.
Hoffmann-La Roche Ltd.
Dr. Viswanadhan holds an undergraduate and doctorate degree from Rutgers State University of New Jersey and an MBA from Cornell University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CARGO THERAPEUTICS, INC.
-.--% | 05/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Krishnan Viswanadhan
| Società | Posizione | Inizio |
|---|---|---|
| CARGO THERAPEUTICS, INC. | Director/Board Member | 01/10/2022 |
| JW (CAYMAN) THERAPEUTICS CO. LTD | Director/Board Member | 20/11/2019 |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Director/Board Member | - |
Be Biopharma, Inc.
 Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | President | 01/07/2021 |
Precedenti posizioni note di Krishnan Viswanadhan
| Società | Posizione | Fine |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/08/2019 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Formazione di Krishnan Viswanadhan
| Rutgers State University of New Jersey | Doctorate Degree |
| Cornell University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| JW (CAYMAN) THERAPEUTICS CO. LTD | Health Technology |
| CARGO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Health Technology |
Be Biopharma, Inc.
Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Krishnan Viswanadhan
